CN114392492B - Intelligent nondestructive phototherapy system - Google Patents
Intelligent nondestructive phototherapy system Download PDFInfo
- Publication number
- CN114392492B CN114392492B CN202210003888.9A CN202210003888A CN114392492B CN 114392492 B CN114392492 B CN 114392492B CN 202210003888 A CN202210003888 A CN 202210003888A CN 114392492 B CN114392492 B CN 114392492B
- Authority
- CN
- China
- Prior art keywords
- eye information
- module
- phototherapy
- treatment
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/11—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils
- A61B3/112—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils for measuring diameter of pupils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Description
技术领域technical field
本发明涉及生命健康技术领域,具体而言,涉及一种智能化无损光疗系统。The invention relates to the technical field of life and health, in particular to an intelligent non-destructive phototherapy system.
背景技术Background technique
神经退行性疾病(Neurodegenerativediseases,NDs)是一种常见的慢性增龄性疾病,影响中枢神经系统和周围神经系统,其特征是以前完整的神经功能不可逆、进行性丧失,并随着年龄的增长而恶化,包括阿尔茨海默病(Alzheimerdiseases,ADs)、帕金森病(Parkinson’sdisease,PDs)等。目前,ND的主要治疗方法是药剂学,但现有的药物只能缓解症状,且有副作用,如腹泻、恶心、头痛等。此外,针对ND的病情特点,治疗不局限于医疗机构,更重要的是日常的居家护理。Neurodegenerative diseases (Neurodegenerative diseases, NDs) are common chronic aging diseases, affecting the central nervous system and peripheral nervous system, characterized by irreversible, progressive loss of previously complete neurological function, and with age Deterioration, including Alzheimer's disease (Alzheimerdiseases, ADs), Parkinson's disease (Parkinson'sdisease, PDs), etc. Currently, the main treatment for ND is pharmacology, but the existing drugs can only relieve symptoms and have side effects, such as diarrhea, nausea, and headache. In addition, according to the characteristics of ND, the treatment is not limited to medical institutions, but more importantly, daily home care.
光学疗法(Lighttherapy,LT)是一种利用光线照射损伤部位从而缓解或治疗疾病的一种无创或微创治疗手段,无副作用。目前,光学疗法形成了包括强激光治疗、光动力治疗、弱激光治疗在内的三大光学治疗技术,已广泛应用于多种疾病的治疗。随着医学治疗模式的转变,弱激光治疗的疾病谱从常见病逐渐拓展到重大慢性增龄性疾病,治疗领域也从疾病治疗延伸到疾病预防,其应用的主战场也从医疗机构逐渐向社区和家庭倾斜。Light therapy (Light therapy, LT) is a non-invasive or minimally invasive treatment method that uses light to irradiate the damaged part to relieve or treat the disease, without side effects. At present, optical therapy has formed three major optical therapy technologies including strong laser therapy, photodynamic therapy, and weak laser therapy, which have been widely used in the treatment of many diseases. With the transformation of the medical treatment model, the disease spectrum of weak laser therapy has gradually expanded from common diseases to major chronic aging diseases, and the field of treatment has also extended from disease treatment to disease prevention. The main battlefield of its application has gradually shifted from medical institutions to communities. and family tilt.
目前,尚无针对ND治疗的弱激光治疗系统。Currently, there is no weak laser therapy system for ND treatment.
发明内容Contents of the invention
本发明提供一种智能化无损光疗系统,用以克服现有技术中存在的至少一个技术问题。The invention provides an intelligent nondestructive phototherapy system to overcome at least one technical problem in the prior art.
本发明实施例提供一种智能化无损光疗系统,所述光疗系统包括:监控模块、处理模块和光疗模块,所述监控模型和所述处理模块连接,所述处理模块和所述光疗模块连接;所述监控模块获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息发送给所述处理模块,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段;所述处理模块根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数;根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数发送给所述光疗模块;所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率;所述光疗模块根据接收到的所述第二治疗参数调整治疗光源的光照剂量。An embodiment of the present invention provides an intelligent non-destructive phototherapy system, the phototherapy system includes: a monitoring module, a processing module and a phototherapy module, the monitoring model is connected to the processing module, and the processing module is connected to the phototherapy module; The monitoring module acquires the patient's first eye information and second eye information, and sends the first eye information and the second eye information to the processing module, and the first eye information and The second eye information includes the size of the pupil, the distribution of the capillaries of the eye, and the acquisition time interval between the first eye information and the second eye information is a preset time period; the processing module according to the acquired The first eye information and the second eye information generate the current change parameters of the patient's eyes; generate the second treatment parameters according to the change parameters, the current first treatment parameters and the preset adjustment range, and sending the second treatment parameter to the phototherapy module; the first treatment parameter and the second treatment parameter include light power and light frequency; the phototherapy module adjusts according to the received second treatment parameter The light dose of the therapeutic light source.
可选的,所述第一眼部信息包括第一时刻眼部信息和第二时刻的眼部信息,所述第二眼部信息包括第三时刻眼部信息和第四时刻的眼部信息;所述处理模块根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数的步骤,包括:所述处理模块根据所述第一时刻的眼部信息和第二时刻的眼部信息,生成患者的第一眼部信息;根据所述第三时刻的眼部信息和第四时刻的眼部信息,生成患者的第二眼部信息;其中,所述第一时刻和所述第二时刻、所述第三时刻和所述第四时刻均间隔预设的第一时段,所述第二时刻和所述第三时刻间隔预设的第二时段。Optionally, the first eye information includes eye information at the first moment and eye information at the second moment, and the second eye information includes eye information at the third moment and eye information at the fourth moment; The step of the processing module generating the current change parameters of the patient's eyes according to the acquired first eye information and the second eye information includes: the processing module according to the first moment The eye information and the eye information at the second moment generate the first eye information of the patient; according to the eye information at the third moment and the eye information at the fourth moment, generate the second eye information of the patient; wherein , the first moment and the second moment, the third moment and the fourth moment are separated by a preset first period, and the second moment and the third moment are separated by a preset second time period.
可选的,所述第一眼部信息和第二眼部信息还包括眨眼频率;所述变化参数包括:瞳孔变量、眼球血丝分布密度变量和眨眼频率变量;第二治疗参数包括第三治疗参数和第四治疗参数;所述根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数的步骤,包括:所述处理模块根据患者的瞳孔变化量、眼球血丝分布密度变化量和眨眼频率变化量,计算当前的适应度值;所述处理模块根据所述适应度值和预设的适应度值分区表,判断当前的所述第一治疗参数是否与所述患者匹配;若匹配,则所述处理模块基于所述第一治疗参数,上调预设的调整幅度,生成第三治疗参数;若不匹配,则所述处理模块根据所述第一治疗参数和预设的调整幅度,下调治疗参数,生成第四治疗参数。Optionally, the first eye information and the second eye information also include blink frequency; the change parameters include: pupil variable, blood capillary distribution density variable, and blink frequency variable; the second treatment parameter includes a third treatment parameter and the fourth treatment parameter; the step of generating the second treatment parameter according to the change parameter, the current first treatment parameter and the preset adjustment range includes: the processing module according to the patient's pupil variation, bloodshot eyes The distribution density variation and the blink frequency variation are used to calculate the current fitness value; the processing module judges whether the current first treatment parameter is consistent with the The patients match; if they match, the processing module increases the preset adjustment range based on the first treatment parameter to generate a third treatment parameter; if not, the processing module Set the adjustment range, down-regulate the treatment parameters, and generate the fourth treatment parameters.
可选的,所述预设的适应度值分区表包括多个适应度值所在区间与评价的一一对应关系,所述评价包括适应、轻度不适应、不适应、严重不适应。Optionally, the preset fitness value partition table includes a one-to-one correspondence between multiple intervals of fitness values and evaluations, and the evaluations include adaptation, mild incompatibility, incompatibility, and severe incompatibility.
可选的,所述所述处理模块根据所述第一治疗参数和预设的调整幅度,下调治疗参数,生成第四治疗参数的步骤,包括:若所述适应度值在所述预设的适应度值分区表中的评价为轻度不适应,则确定实际下调幅度为一倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为不适应,则确定实际下调幅度为两倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为严重不适应,则确定实际下调幅度为三倍的预设的调整幅度;在所述第一治疗参数的基础上,下调所述实际下调幅度,生成第四治疗参数。Optionally, the processing module, according to the first treatment parameter and a preset adjustment range, down-regulates the treatment parameter to generate a fourth treatment parameter, including: if the fitness value is within the preset The evaluation in the fitness value partition table is mild incompatibility, then it is determined that the actual down-regulation range is the preset adjustment range of one time; if the evaluation of the fitness value in the preset fitness value partition table is If not suitable, then determine that the actual down-regulation range is twice the preset adjustment range; if the evaluation of the fitness value in the preset fitness value partition table is seriously unsuitable, then determine that the actual down-regulation range is three times the preset adjustment range; on the basis of the first treatment parameter, down-regulate the actual down-regulation range to generate a fourth treatment parameter.
可选的,所述评价还包括过敏;在所述所述处理模块根据所述适应度值,在预设的适应度值分区表中找到对应的适应度值的评价的步骤之后,所述方法还包括:若评价为过敏,则所述处理模块向所述光疗模块发送停止治疗指令;所述光疗模块在接收到所述停止治疗指令后,关闭所述治疗光源。Optionally, the evaluation also includes allergies; after the processing module finds the evaluation of the corresponding fitness value in the preset fitness value partition table according to the fitness value, the method It also includes: if it is evaluated as allergic, the processing module sends an instruction to stop treatment to the phototherapy module; after receiving the instruction to stop treatment, the phototherapy module turns off the treatment light source.
可选的,所述系统还包括调整模块;所述调整模块获取第五治疗参数,将所述第五治疗参数发送给所述光疗模块;所述光疗模块根据接收到的所述第五治疗参数对光源的光照剂量进行调整。Optionally, the system further includes an adjustment module; the adjustment module obtains a fifth treatment parameter, and sends the fifth treatment parameter to the phototherapy module; the phototherapy module Adjust the light dose of the light source.
可选的,所述智能化无损光疗系统包括智能化无损化光疗眼镜;所述治疗模块为所述智能化无损化光疗眼镜上的透明LED脉冲光镜片;所述监控模块为设置在所智能化无损化光疗眼镜镜框上的超清监控摄像头。Optionally, the intelligent non-destructive phototherapy system includes intelligent non-destructive phototherapy glasses; the treatment module is a transparent LED pulse light lens on the intelligent non-destructive phototherapy glasses; The ultra-clear surveillance camera on the frame of non-destructive phototherapy glasses.
可选的,所述处理模块为设置在所述智能化无损化光疗眼镜上的微型处理器;所述调整模块设置在所述智能化无损化光疗眼镜侧面的镜腿部位,所述调整模块包括用于提高光照剂量的增量按键和用于降低光照剂量的减量按键;所述微型处理器分别与所述LED脉冲光镜片、超清监控摄像头和所述调整模块有线或无线连接。Optionally, the processing module is a microprocessor arranged on the intelligent non-destructive phototherapy glasses; the adjustment module is arranged on the side temples of the intelligent non-destructive phototherapy glasses, It includes an increment key for increasing the light dose and a decrement key for reducing the light dose; the microprocessor is respectively wired or wirelessly connected with the LED pulse light lens, the ultra-clear monitoring camera and the adjustment module.
可选的,所述智能化无损光疗系统还包括远程操作终端;所述智能化无损化光疗眼镜还包括第一通信模块;所述远程操作终端中设置有所述处理模块、所述调整模块和第二通信模块;所述智能化无损化光疗眼镜和所述远程操作终端分别通过所述第一通信模块和所述第二通信模块连接。Optionally, the intelligent nondestructive phototherapy system further includes a remote operation terminal; the intelligent nondestructive phototherapy glasses further include a first communication module; the remote operation terminal is provided with the processing module, the adjustment module and The second communication module; the intelligent non-destructive phototherapy glasses and the remote operation terminal are respectively connected through the first communication module and the second communication module.
本发明实施例的创新点包括:The innovations of the embodiments of the present invention include:
1、本发明提出的智能化无损光疗系统,可以使用弱激光对神经退行性疾病(NDs)的患者进行治疗,相对药物治疗,本发明的光疗系统治疗对患者身体无任何副作用。是本发明实施例的创新点之一。1. The intelligent non-destructive phototherapy system proposed by the present invention can use weak laser to treat patients with neurodegenerative diseases (NDs). Compared with drug treatment, the phototherapy system of the present invention has no side effects on the patient's body. It is one of the innovative points of the embodiment of the present invention.
2、本发明提出的智能化无损光疗系统中,处理模块可以根据监控模块实时监控患者的眼部情况,并根据患者当前的眼部情况自动调节光疗模块的光照剂量,使用方便且安全可靠,无需具备专业技能,便于患者居家使用。是本发明实施例的创新点之一。2. In the intelligent nondestructive phototherapy system proposed by the present invention, the processing module can monitor the patient's eye condition in real time according to the monitoring module, and automatically adjust the light dose of the phototherapy module according to the patient's current eye condition, which is convenient, safe and reliable, and does not require With professional skills, it is convenient for patients to use at home. It is one of the innovative points of the embodiment of the present invention.
3、本发明提出的智能化无损光疗系统中,处理模块可以根据患者当前时间段的眼部信息,自动对光疗模块的光照剂量进行分阶段调整,避免出现由于光照剂量较大造成的患者眼部不适,以及光照剂量不足导致的治疗效果不佳等问题,兼顾患者体验感和治疗效果,以实现在患者眼部较为舒适的前提下,最大程度的提升治疗效果。是本发明实施例的创新点之一。3. In the intelligent non-destructive phototherapy system proposed by the present invention, the processing module can automatically adjust the light dose of the phototherapy module in stages according to the eye information of the patient in the current time period, so as to avoid the patient's eye damage caused by the large light dose. Discomfort, as well as poor treatment effect caused by insufficient light dose, take into account the patient's experience and treatment effect, so as to achieve the maximum improvement of the treatment effect on the premise that the patient's eyes are more comfortable. It is one of the innovative points of the embodiment of the present invention.
4、本发明提出的智能化无损光疗系统,小巧便捷,可随身携带,适于家庭的日常护理治疗,具体的,可以佩戴在患者头部,由于LED脉冲光镜片为透明,患者在治疗过程中视线不受影响,可以自由行动,使用起来非常方便,有较佳的使用体验。是本发明实施例的创新点之一。4. The intelligent non-destructive phototherapy system proposed by the present invention is small and convenient, can be carried around, and is suitable for daily care and treatment at home. Specifically, it can be worn on the patient's head. Since the LED pulsed light lens is transparent, the patient can The line of sight is not affected, and you can move freely. It is very convenient to use and has a better user experience. It is one of the innovative points of the embodiment of the present invention.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. Those skilled in the art can also obtain other drawings based on these drawings without creative work.
图1为本发明提出的一种智能化无损光疗系统;Fig. 1 is a kind of intelligent nondestructive phototherapy system that the present invention proposes;
图2为本发明提出的另一种智能化无损光疗系统;Fig. 2 is another intelligent nondestructive phototherapy system proposed by the present invention;
图3为本发明中步骤213的具体处理流程图;Fig. 3 is the specific processing flowchart of
图4为本发明提出的智能化无损化光疗眼镜;Fig. 4 is the intelligent non-destructive phototherapy glasses proposed by the present invention;
图5为本发明提出的智能化无损化光疗眼镜和远程操作终端。Fig. 5 shows the intelligent non-destructive phototherapy glasses and the remote operation terminal proposed by the present invention.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
需要说明的是,本发明实施例及附图中的术语“包括”和“具有”以及它们任何变形,意图在于覆盖不排他的包含。例如包含了一系列步骤或单元的过程、方法、系统、产品或设备没有限定于已列出的步骤或单元,而是可选地还包括没有列出的步骤或单元,或可选地还包括对于这些过程、方法、产品或设备固有的其它步骤或单元。It should be noted that the terms "include" and "have" and any variations thereof in the embodiments of the present invention and drawings are intended to cover non-exclusive inclusion. For example, a process, method, system, product or device comprising a series of steps or units is not limited to the listed steps or units, but optionally also includes unlisted steps or units, or optionally further includes For other steps or units inherent in these processes, methods, products or apparatuses.
本发明提出了一种智能化无损光疗系统,参考图1,图1为本发明提出的一种智能化无损光疗系统。如图1所示,智能化无损光疗系统包括:监控模块、处理模块和光疗模块,所述监控模块和所述处理模块连接,所述处理模块和所述光疗模块连接。光疗系统中各模块的交互流程如下:The present invention proposes an intelligent non-destructive phototherapy system, refer to FIG. 1 , which is an intelligent non-destructive phototherapy system proposed by the present invention. As shown in FIG. 1 , the intelligent nondestructive phototherapy system includes: a monitoring module, a processing module and a phototherapy module, the monitoring module is connected to the processing module, and the processing module is connected to the phototherapy module. The interaction process of each module in the phototherapy system is as follows:
步骤101,所述监控模块获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息发送给所述处理模块。
其中,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段。Wherein, the first eye information and the second eye information include pupil size and bloodshot distribution of the eyeball, and the acquisition time interval of the first eye information and the second eye information is a preset time period.
在本步骤中,监控模块可以获取患者的第一眼部信息和第二眼部信息,其中,第一眼部信息的获取时间与第二眼部时间的获取时间可以间隔预设时间段,预设时间段可以为10 100μs,第一眼部信息和第二眼部信息可以反应附近这段时间内患者眼部的变化情况,为后续步骤判断光疗模块的治疗参数是否合适提供参考。In this step, the monitoring module can acquire the first eye information and the second eye information of the patient, wherein the acquisition time of the first eye information and the acquisition time of the second eye time can be separated by a preset time period, Assuming that the time period can be 10 100 μs, the first eye information and the second eye information can reflect the changes in the patient's eyes during this period of time, and provide a reference for the subsequent steps to judge whether the treatment parameters of the phototherapy module are appropriate.
需要说明的是,光疗模块是通过照射患者眼部达到治疗效果的,为了实时监测患者的眼部情况,第一眼部信息和第二眼部信息可以包括患者的瞳孔大小、眼球血丝分布情况等能够反应患者对光疗模块治疗的适应程度的患者的临床数据。It should be noted that the phototherapy module achieves the therapeutic effect by irradiating the patient's eyes. In order to monitor the patient's eye condition in real time, the first eye information and the second eye information can include the patient's pupil size, eye blood filament distribution, etc. The patient's clinical data that can reflect the patient's degree of adaptation to the treatment of the phototherapy module.
可以理解的,当光疗模块的治疗参数不合适时,可能造成患者的瞳孔变化幅度较大,眼球血丝增多等不良反应。It is understandable that when the treatment parameters of the phototherapy module are inappropriate, it may cause adverse reactions such as large changes in the pupils of the patient and increased bloodshot eyes.
步骤103,所述处理模块根据接收到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数。
在本步骤中,处理模块可以根据监控模块发送的第一眼部信息和第二眼部信息,生成反应患者当前对光疗模块治疗效果反应程度的变化参数,达到实时监控患者眼部情况的目的。In this step, the processing module can generate changing parameters that reflect the patient's current response to the treatment effect of the phototherapy module according to the first eye information and the second eye information sent by the monitoring module, so as to achieve the purpose of real-time monitoring of the patient's eye condition.
需要说明的是,变化参数可以体现第一眼部信息和第二眼部信息的获取时间段内,也即当前时间内的眼部变化情况。如果变化参数较大,说明患者眼部不适应当前的治疗光源,也可能已出现过敏反应,可以通过修改治疗参数降低光照剂量,或者停止光疗。It should be noted that the change parameter may reflect the change of the eye within the acquisition time period of the first eye information and the second eye information, that is, within the current time. If the parameter changes are large, it means that the patient's eyes are not adapted to the current treatment light source, and an allergic reaction may have occurred. The light dose can be reduced by modifying the treatment parameters, or the phototherapy can be stopped.
步骤105,所述处理模块根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数发送给所述光疗模块。
其中,所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率。Wherein, the first treatment parameter and the second treatment parameter include illumination power and illumination frequency.
在本步骤中,处理模块可以根据生成的变化参数,确定当前的第一治疗参数对患者是否合适,若合适,则可以按照预设的调整幅度,在当前的第一治疗参数的基础上,上调各项治疗参数,若不合适,则可以根据预设的调整幅度,在第一治疗参数的基础上,下调各项治疗参数,最终得到与患者当前状态匹配的第二治疗参数,并且将第二治疗参数发送给光疗模块,以便光疗模块及时调整治疗参数,调整光照剂量。一方面,在患者的身体可以接受的前提下,提高光照剂量,增进治疗效果,另一方面,若患者出现不适反应,则可以及时降低光照剂量甚至停止光疗,以提高患者的使用体验。In this step, the processing module can determine whether the current first treatment parameter is suitable for the patient according to the generated change parameters. If the treatment parameters are not suitable, you can adjust the treatment parameters down on the basis of the first treatment parameters according to the preset adjustment range, and finally get the second treatment parameters that match the current state of the patient. The treatment parameters are sent to the phototherapy module, so that the phototherapy module can adjust the treatment parameters and the light dose in time. On the one hand, on the premise that the patient's body can accept it, the light dose can be increased to improve the therapeutic effect. On the other hand, if the patient has an uncomfortable reaction, the light dose can be reduced or even stopped in time to improve the patient's experience.
需要说明的是,光疗模块可以为LED脉冲光模块,治疗参数可以包括光照功率、光照频率等能够影响光疗模块的光照剂量的参数。It should be noted that the phototherapy module may be an LED pulsed light module, and the treatment parameters may include light power, light frequency and other parameters that can affect the light dose of the phototherapy module.
步骤107,所述疗模块根据接收到的所述第二治疗参数调整治疗光源的光照剂量。
在本步骤中,光疗模块可以根据处理模块发送的新生成的第二治疗参数,调整治疗光源的光照功率和光照频率等治疗参数,以使治疗光源的光照剂量与患者的眼部情况相适应,避免出现眼部过敏或眼部不适,提升患者的使用体验。In this step, the phototherapy module can adjust treatment parameters such as light power and light frequency of the treatment light source according to the newly generated second treatment parameters sent by the processing module, so that the light dose of the treatment light source is adapted to the patient's eye condition, Avoid eye allergies or eye discomfort, and improve patient experience.
可见,本发明提出的智能化无损光疗系统,相对药物治疗,本发明的光疗系统治疗对患者身体无任何副作用;此外,处理模块可以通过监控模块实时监测患者的眼部情况并根据患者当前的眼部情况自动调节光疗模块的光照剂量,使用方便且安全可靠,无需具备专业技能,便于患者居家使用,并且可以提升患者的使用体验。It can be seen that the intelligent non-destructive phototherapy system proposed by the present invention has no side effects on the patient's body compared with drug treatment; in addition, the processing module can monitor the patient's eye condition in real time through the monitoring module and according to the patient's current eye condition. The light dose of the phototherapy module can be automatically adjusted according to the local conditions. It is easy to use, safe and reliable, and does not require professional skills. It is convenient for patients to use at home and can improve the patient's experience.
本发明还提出另一种智能化无损光疗系统,参考图2,图2为本发明提出的另一种智能化无损光疗系统。如图2所示,另一种智能化无损光疗系统的处理步骤如下:The present invention also proposes another intelligent non-destructive phototherapy system, refer to FIG. 2 , which is another intelligent non-destructive phototherapy system proposed by the present invention. As shown in Figure 2, the processing steps of another intelligent nondestructive phototherapy system are as follows:
步骤201,所述监控模块获取患者的第一时刻的眼部信息、第二时刻的眼部信息、第三时刻的眼部信息和第四时刻的眼部信息。
其中,所述第一时刻和所述第二时刻、所述第三时刻和所述第四时刻均间隔预设的第一时段,所述第二时刻和所述第三时刻间隔预设的第二时段。Wherein, the first moment and the second moment, the third moment and the fourth moment are separated by a preset first time period, and the second moment and the third moment are separated by a preset first time period. Second period.
需要说明的是,第一时刻和第二时刻,第三时刻和第四时刻均间隔预设的第一时段,预设的第一时段可以是根据实际情况设置,通常情况下可以设置为10μs。第二时刻和第三时刻的间隔为预设的第二时段,通常情况下可以设置为100μs。It should be noted that the interval between the first moment and the second moment, and between the third moment and the fourth moment is a preset first period, which can be set according to the actual situation, and usually can be set to 10 μs. The interval between the second moment and the third moment is a preset second period, which can be set to 100 μs under normal circumstances.
步骤203,所述处理模块根据所述第一时刻的眼部信息和第二时刻的眼部信息,生成患者的第一眼部信息;根据所述第三时刻的眼部信息和第四时刻的眼部信息,生成患者的第二眼部信息。
在本步骤中,处理模块可以根据监控模块发送的第一时刻的眼部信息和第二时刻的眼部信息,生成患者的第一眼部信息,第一眼部信息可以是第一时刻的眼部信息和第二时刻的眼部信息的均值,也可以是基于第一时刻的眼部信息和第二时刻的眼部信息,经数据处理后得到的数值。同理,第二眼部信息也是基于第三时刻的眼部信息和第四时刻的眼部信息得到的。In this step, the processing module can generate the first eye information of the patient according to the eye information at the first moment and the eye information at the second moment sent by the monitoring module. The first eye information can be the eye information at the first moment. The average value of the facial information and the eye information at the second moment may also be a value obtained after data processing based on the eye information at the first moment and the eye information at the second moment. Similarly, the second eye information is also obtained based on the eye information at the third moment and the eye information at the fourth moment.
步骤205,所述处理模块根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数。
需要说明的是,所述第一眼部信息和第二眼部信息还包括眨眼频率;对应的,所述变化参数可以包括:瞳孔变量、眼球血丝分布密度变量和眨眼频率变量等能够反应眼部适应程度的参数。It should be noted that the first eye information and the second eye information also include blinking frequency; correspondingly, the change parameters may include: pupil variables, bloodshot distribution density variables and blinking frequency variables, etc., which can reflect eye parameters of fitness.
步骤207,所述处理模块根据患者的瞳孔变化量、眼球血丝分布密度变化量和眨眼频率变化量,计算当前的适应度值。
在本步骤中,处理模块可以根据患者的瞳孔变化量、眼球血丝分布密度变化量和眨眼频率变化量,计算患者当前的适应度值。In this step, the processing module may calculate the patient's current fitness value according to the patient's pupil variation, eye capillary distribution density variation, and eye blink frequency variation.
具体的,计算适应度值的公式如下所示:Specifically, the formula for calculating the fitness value is as follows:
x=50%·a+20%·b+30%·c(1)x=50%·a+20%·b+30%·c(1)
在公式(1)中,a为瞳孔变量,b为眼球血丝分布密度变量,c为眨眼频率变化量。In the formula (1), a is the variable of the pupil, b is the variable of the distribution density of blood capillaries, and c is the variation of the blinking frequency.
需要说明的是,各变化量对应的权重值,比如在公式(1)中瞳孔变量对应的50%权重值,眼球血丝分布密度变量对应的20%权重值,眨眼频率变化量对应的30%权重值,均可以根据实际情况来调整。It should be noted that the weight values corresponding to each change amount, such as the 50% weight value corresponding to the pupil variable in the formula (1), the 20% weight value corresponding to the bloodshot distribution density variable, and the 30% weight value corresponding to the blink frequency change amount The value can be adjusted according to the actual situation.
步骤209,所述处理模块根据所述适应度值和预设的适应度值分区表,判断当前的所述第一治疗参数是否与所述患者匹配;若匹配,则执行步骤211,若不匹配,则执行步骤213。
在本步骤中,处理模块可以根据计算出的适应度值,在预设的适应度值分区表中进行查询,根据查询结果判断光疗模块当前使用的第一治疗参数,是否与患者的眼部状态相匹配。若匹配,则执行步骤207,以便及时增大光疗模块的光照剂量,提高治疗效果,若不匹配,则执行步骤209,以及时降低光照剂量,避免对患者身体造成损伤。In this step, the processing module can query the preset fitness value partition table according to the calculated fitness value, and judge whether the first treatment parameter currently used by the phototherapy module is consistent with the patient's eye state according to the query result. match. If they match, perform
在本步骤中,处理模块可以根据计算出的适应度值,在预设的适应度值分区表中找到与适应度值对应的评价,以进一步确定与患者身体相匹配的处理方式。In this step, the processing module can find the evaluation corresponding to the fitness value in the preset fitness value partition table according to the calculated fitness value, so as to further determine the treatment method that matches the patient's body.
可选的,所述预设的适应度值分区表可以包括多个适应度值所在区间与评价的一一对应关系,所述评价可以包括适应、轻度不适应、不适应、严重不适应和过敏。具体的,预设的适应度值分区表可以如表1所示。Optionally, the preset fitness value partition table may include a one-to-one correspondence between multiple intervals of fitness values and evaluations, and the evaluations may include adaptation, mild discomfort, incompatibility, severe incompatibility and allergy. Specifically, the preset fitness value partition table may be as shown in Table 1.
表1Table 1
当然,在实际应用中,可以根据患者的身体情况,设置预设的适应度值分区表。Of course, in practical applications, a preset fitness value partition table can be set according to the physical condition of the patient.
步骤211,所述处理模块基于所述第一治疗参数,上调预设的调整幅度,生成第三治疗参数,以及将所述第三治疗参数发送给所述光疗模块。
在本步骤中,由于光疗模块当前使用的第一治疗参数,与患者的眼部状态相匹配,因此,可以基于所述第一治疗参数,上调预设的调整幅度,生成第三治疗参数,以及将所述第三治疗参数发送给所述光疗模块,这样可以在患者的眼部舒适的前提下,及时增大光疗模块的光照剂量,提高治疗效果。In this step, since the first treatment parameter currently used by the phototherapy module matches the eye state of the patient, based on the first treatment parameter, the preset adjustment range can be raised to generate a third treatment parameter, and The third treatment parameter is sent to the phototherapy module, so that the light dose of the phototherapy module can be increased in time on the premise that the eyes of the patient are comfortable, and the treatment effect can be improved.
通常情况下,预设的调整幅度可以为10 40HZ。Normally, the preset adjustment range can be 10 40HZ.
需要说明的是,为了与前一个实施例对应,前一个实施例中出现的第二治疗参数可以包括本实施例中的第三治疗参数和第四治疗参数。It should be noted that, in order to correspond to the previous embodiment, the second treatment parameter in the previous embodiment may include the third treatment parameter and the fourth treatment parameter in this embodiment.
步骤213,所述处理模块根据所述第一治疗参数和预设的调整幅度,下调治疗参数,生成第四治疗参数,以及将所述第四治疗参数发送给所述光疗模块。
在本步骤中,由于光疗模块当前使用的第一治疗参数,与患者的眼部状态不匹配,因此,可以基于所述第一治疗参数,下调预设的调整幅度,生成第四治疗参数,以及将所述第四治疗参数发送给所述光疗模块,以改善患者眼部的不良状态,避免对患者身体造成损伤,提升患者体验。In this step, since the first treatment parameter currently used by the phototherapy module does not match the eye state of the patient, the preset adjustment range can be lowered based on the first treatment parameter to generate a fourth treatment parameter, and The fourth treatment parameter is sent to the phototherapy module, so as to improve the bad state of the patient's eyes, avoid damage to the patient's body, and improve the patient's experience.
可选的,参考图3,图3为本发明中步骤209的具体处理流程图,如图3所示,步骤213具体可以包括:Optionally, refer to FIG. 3. FIG. 3 is a specific processing flowchart of
子步骤31,若所述适应度值在所述预设的适应度值分区表中的评价为轻度不适应,则确定实际下调幅度为一倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为不适应,则确定实际下调幅度为两倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为严重不适应,则确定实际下调幅度为三倍的预设的调整幅度。Sub-step 31, if the evaluation of the fitness value in the preset fitness value partition table is mildly unsuitable, then determine that the actual down-regulation range is double the preset adjustment range; if the fitness value If the evaluation of the value in the preset fitness value partition table is unsuitable, then it is determined that the actual down-regulation range is twice the preset adjustment range; if the fitness value is in the preset fitness value partition If the evaluation in the table is seriously unsuitable, then the actual down-regulation range is determined to be three times the preset adjustment range.
子步骤32,在所述第一治疗参数的基础上,下调所述实际下调幅度,生成第四治疗参数。Sub-step 32, on the basis of the first treatment parameter, down-regulate the actual down-regulation range to generate a fourth treatment parameter.
具体的,在当前的光疗模块的光照剂量与患者不匹配的情况下,更加细化下调光照剂量的实现方式,分阶段下调光照剂量,评价较轻的,光照剂量的下调幅度较小,评价较严重的,光照剂量的下调幅度较大。在对患者身体不造成损伤的情况下,尽量保证光疗模块的治疗效果。Specifically, in the case that the light dose of the current phototherapy module does not match the patient, the implementation method of reducing the light dose will be more detailed, and the light dose will be reduced in stages. Seriously, the reduction of light dose is relatively large. In the case of not causing damage to the patient's body, try to ensure the therapeutic effect of the phototherapy module.
可选的,所述评价还可以包括过敏;Optionally, the evaluation may also include allergies;
若评价为过敏,则所述处理模块向所述光疗模块发送停止治疗指令;If it is evaluated as allergic, the processing module sends an instruction to stop treatment to the phototherapy module;
所述光疗模块在接收到所述停止治疗指令后,关闭所述治疗光源。The phototherapy module turns off the treatment light source after receiving the instruction to stop treatment.
具体的,当适应度值在预设的适应度值分区表中对应的评价为过敏时,说明患者的眼部已经出现过敏状态,处理模块立刻向所述光疗模块发送停止治疗指令,光疗模块在接收到所述停止治疗指令后,关闭所述治疗光源,以避免加重患者眼部的过敏情况。Specifically, when the fitness value is evaluated as allergic in the preset fitness value partition table, it means that the patient’s eyes have been allergic, and the processing module immediately sends a treatment stop instruction to the phototherapy module. After receiving the instruction to stop the treatment, the treatment light source is turned off, so as to avoid aggravating the allergic condition of the patient's eyes.
具体的,瞳孔变量的预设区间可以为2.5 4mm,当瞳孔变量超过该预设区间时,处理模块向光疗模块发送停止治疗指令;眼球血丝分布密度变量的预设区间可以为5%5%,当眼球血丝分布密度变量超出该预设区间时,处理模块向光疗模块发送停止治疗指令;眨眼频率变化量的预设区间可以为10 30次/分钟,当眨眼频率变化量该预设区域间时,处理模块向光疗模块发送停止治疗指令。Specifically, the preset interval of the pupil variable can be 2.5-4mm. When the pupil variable exceeds the preset interval, the processing module sends an instruction to stop the treatment to the phototherapy module; the preset interval of the bloodshot distribution density variable can be 5% to 5%, When the bloodshot distribution density variable of the eyeball exceeds the preset interval, the processing module sends an instruction to stop the treatment to the phototherapy module; the preset interval of the blink frequency variation can be 10-30 times/minute, when the blink frequency variation is within the preset range , the processing module sends a treatment stop instruction to the phototherapy module.
在具体实施中,所述系统还包括调整模块;In a specific implementation, the system also includes an adjustment module;
所述调整模块获取第五治疗参数,将所述第五治疗参数发送给所述光疗模块;The adjustment module acquires a fifth treatment parameter, and sends the fifth treatment parameter to the phototherapy module;
所述光疗模块根据接收到的所述第五治疗参数对光源的光照剂量进行调整。The phototherapy module adjusts the light dose of the light source according to the received fifth treatment parameter.
具体的,在部分场地下,可以通过调整模块手动输入治疗参数,记为第五治疗参数,由调整模块将第五治疗参数发送给光疗模块,以便光疗模块将光源的光照剂量按照第五治疗参数进行调整。Specifically, in some venues, the treatment parameters can be manually input through the adjustment module, which is recorded as the fifth treatment parameter, and the adjustment module will send the fifth treatment parameter to the phototherapy module, so that the phototherapy module will adjust the light dose of the light source according to the fifth treatment parameter. Make adjustments.
可见,本发明提出的另一种智能化无损光疗系统,处理模块可以根据患者当前时间段的眼部信息,自动对光疗模块的光照剂量进行分阶段调整,避免出现由于光照剂量较大造成的患者眼部不适,以及光照剂量不足导致的治疗效果不佳等问题,兼顾患者体验感和治疗效果,以实现在患者眼部较为舒适的前提下,最大程度的提升治疗效果。It can be seen that in another intelligent non-destructive phototherapy system proposed by the present invention, the processing module can automatically adjust the light dose of the phototherapy module in stages according to the eye information of the patient in the current time period, so as to avoid the occurrence of patients with high light dose. For problems such as eye discomfort and poor treatment effect caused by insufficient light dose, the patient's experience and treatment effect are taken into consideration, so as to maximize the treatment effect on the premise that the patient's eyes are more comfortable.
在具体实施中,本发明提出的智能化无损光疗系统具体可以是一种智能化无损光疗眼镜。参考图4,图4为本发明提出的智能化无损化光疗眼镜。In a specific implementation, the intelligent nondestructive phototherapy system proposed by the present invention may specifically be a kind of intelligent nondestructive phototherapy glasses. Referring to Fig. 4, Fig. 4 shows the intelligent non-destructive phototherapy glasses proposed by the present invention.
如图4所示,所述治疗模块为所述智能化无损化光疗眼镜40上的透明LED脉冲光镜片401;所述监控模块为设置在所智能化无损化光疗眼镜40镜框上的超清监控摄像头402;所述处理模块为设置在所述光疗眼镜40上的微型处理器403;所述调整模块设置在所述光疗眼镜40侧面的镜腿部位,所述调整模块包括用于提高光照剂量的按键404,具体包括增量按键和减量按键。As shown in Figure 4, the treatment module is a transparent LED
所述微型处理器403分别与所述LED脉冲光镜片401、超清监控摄像头402和所述调整模块404有线或无线连接。The
具体的,智能化无损化光疗眼镜40内部模块的交互流程如下:Specifically, the interaction process of the internal modules of the intelligent
智能化无损化光疗眼镜40中的所述超清监控摄像头402获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息通过第一通信模块405发送给微型处理器403,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段;The
微型处理器403根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数;根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数通过第二通信模块发送给透明LED脉冲光镜片401;所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率。The
透明LED脉冲光镜片401根据接收到的所述第二治疗参数调整治疗光源的光照剂量。The transparent LED pulsed
处理方法中的具体细节可以参考前文实施例,在此不再赘述。For specific details in the processing method, reference may be made to the foregoing embodiments, and details are not repeated here.
在本实施例中,智能化无损化光疗眼镜能够解决目前治疗仪治疗时无法实时监控治疗过程的问题,可以实时监控患者眼部情况,以自适应调节光治疗剂量。此外,智能化无损化光疗眼镜具有操作自由性,在不影响治疗效果的前提下,患者在接收治疗的同时可以做其他事情,使用方便安全,适用于居家的日常护理。In this embodiment, the intelligent non-destructive phototherapy glasses can solve the problem that the treatment process cannot be monitored in real time during treatment with the current treatment instrument, and can monitor the patient's eye condition in real time to adaptively adjust the phototherapy dose. In addition, the intelligent non-destructive phototherapy glasses have the freedom of operation. Under the premise of not affecting the treatment effect, patients can do other things while receiving treatment. It is convenient and safe to use, and is suitable for daily care at home.
在具体实施中,本发明再提出一种光疗智能装置,具体包括智能化无损化光疗眼镜和远程操作终端。参考图5,图5为本发明提出的智能化无损化光疗眼镜和远程操作终端。In specific implementation, the present invention further proposes a phototherapy smart device, which specifically includes intelligent non-destructive phototherapy glasses and a remote operation terminal. Referring to Fig. 5, Fig. 5 shows the intelligent non-destructive phototherapy glasses and the remote operation terminal proposed by the present invention.
如图5所示,所述光疗智能眼睛40中设置有透明LED脉冲光镜片401、超清监控摄像头402和第一通信模块405。所述远程操作终端50中设置有处理模块501、调整模块502和第二通信模块503。所述第一通信模块405分别与所述超清监控摄像头402、所述透明LED脉冲光镜片401连接。所述远程操作终端50中的第二通讯模块503与所述智能化无损化光疗眼镜40中的第二通讯模块405无线连接。As shown in FIG. 5 , the phototherapy
具体的,智能化无损化光疗眼镜40和远程操作终端50的交互流程如下:Specifically, the interaction process between the intelligent
智能化无损化光疗眼镜40中的所述超清监控摄像头402获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息通过第一通信模块405发送给远程操作终端50中的处理模块501,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段;The
远程操作终端50中的处理模块501根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数;根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数通过第二通信模块发送给智能化无损化光疗眼镜40中的透明LED脉冲光镜片401;所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率;The
智能化无损化光疗眼镜40中的透明LED脉冲光镜片401根据接收到的所述第二治疗参数调整治疗光源的光照剂量。The transparent LED
需要说明的是,远程操作终端50的承载实体可以是手机、平板、电脑,也可以是智能手表等各类智能穿戴产品。远程操作终端50的功能可以通过APP、小程序等多种方式实现。对于远程操作终端50的具体实现方式本文不作限制。It should be noted that the carrying entity of the
处理方法中的细节可以参考前文实施例,在此不再赘述。For details in the processing method, reference may be made to the foregoing embodiments, and details are not repeated here.
在本实施例中,相比智能化无损化光疗眼镜,光疗智能装置的调节使用更加方便,远程操作终端50可以承担更多的个性化功能设置,方便后期的功能拓展和产品升级。In this embodiment, compared with intelligent non-destructive phototherapy glasses, the adjustment and use of the phototherapy smart device is more convenient, and the
本领域普通技术人员可以理解:附图只是一个实施例的示意图,附图中的模块或流程并不一定是实施本发明所必须的。Those skilled in the art can understand that the accompanying drawing is only a schematic diagram of an embodiment, and the modules or processes in the accompanying drawing are not necessarily necessary for implementing the present invention.
本领域普通技术人员可以理解:实施例中的装置中的模块可以按照实施例描述分布于实施例的装置中,也可以进行相应变化位于不同于本实施例的一个或多个装置中。上述实施例的模块可以合并为一个模块,也可以进一步拆分成多个子模块。Those of ordinary skill in the art can understand that: the modules in the device in the embodiment may be distributed in the device in the embodiment according to the description in the embodiment, or may be changed and located in one or more devices different from the embodiment. The modules in the above embodiments can be combined into one module, and can also be further split into multiple sub-modules.
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明实施例技术方案的精神和范围。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: it can still be Modifications are made to the technical solutions described in the foregoing embodiments, or equivalent replacements are made to some of the technical features; these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210003888.9A CN114392492B (en) | 2022-01-05 | 2022-01-05 | Intelligent nondestructive phototherapy system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210003888.9A CN114392492B (en) | 2022-01-05 | 2022-01-05 | Intelligent nondestructive phototherapy system |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114392492A CN114392492A (en) | 2022-04-26 |
CN114392492B true CN114392492B (en) | 2023-02-10 |
Family
ID=81229055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210003888.9A Active CN114392492B (en) | 2022-01-05 | 2022-01-05 | Intelligent nondestructive phototherapy system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114392492B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117101017B (en) * | 2023-10-08 | 2024-09-03 | 广州中科智慧健康产业科技有限公司 | Personalized phototherapy room adjusting method and system based on biofeedback |
CN119257911A (en) * | 2024-10-21 | 2025-01-07 | 湖南赉拓物联网科技有限公司 | A data analysis method and system for a comprehensive myopia and amblyopia treatment device |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6669651B1 (en) * | 2000-02-24 | 2003-12-30 | Matsushita Electric Works, Ltd. | Non-invasive brain function examination |
CN109965870A (en) * | 2019-02-27 | 2019-07-05 | 杭州诺为医疗技术有限公司 | A kind of method of automatic detection and stimulation therapy epilepsy |
CN111414027A (en) * | 2020-04-30 | 2020-07-14 | 厦门中翎易优创科技有限公司 | A thermotherapy device with automatic temperature adjustment |
CN113181016A (en) * | 2021-05-13 | 2021-07-30 | 云南白药集团无锡药业有限公司 | Eye adjustment training lamp with dynamically-changed illumination |
CN113693612A (en) * | 2021-08-16 | 2021-11-26 | 深圳大学 | Senile dementia diagnosis and treatment device |
CN113713256A (en) * | 2021-09-03 | 2021-11-30 | 重庆极治医疗科技有限公司 | Electric field cancer treatment equipment with feedback mechanism and diagnosis function and method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7171271B2 (en) * | 2004-05-11 | 2007-01-30 | Pacesetter, Inc. | System and method for evaluating heart failure using an implantable medical device based on heart rate during patient activity |
UA77510U (en) * | 2012-12-24 | 2013-02-11 | Владимир Ильич Черний | Method for assessing severity of preeclampsia in pregnant patients and efficacy of therapy in dynamics |
CN104189997B (en) * | 2014-07-25 | 2016-02-10 | 深圳市艾尔曼医疗电子仪器有限公司 | Intelligence Feedback high electrograph therapy instrument and Therapeutic Method |
US20160374594A1 (en) * | 2015-06-26 | 2016-12-29 | Koninklijke Philips N.V. | System for monitoring a dopaminergic activity |
-
2022
- 2022-01-05 CN CN202210003888.9A patent/CN114392492B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6669651B1 (en) * | 2000-02-24 | 2003-12-30 | Matsushita Electric Works, Ltd. | Non-invasive brain function examination |
CN109965870A (en) * | 2019-02-27 | 2019-07-05 | 杭州诺为医疗技术有限公司 | A kind of method of automatic detection and stimulation therapy epilepsy |
CN111414027A (en) * | 2020-04-30 | 2020-07-14 | 厦门中翎易优创科技有限公司 | A thermotherapy device with automatic temperature adjustment |
CN113181016A (en) * | 2021-05-13 | 2021-07-30 | 云南白药集团无锡药业有限公司 | Eye adjustment training lamp with dynamically-changed illumination |
CN113693612A (en) * | 2021-08-16 | 2021-11-26 | 深圳大学 | Senile dementia diagnosis and treatment device |
CN113713256A (en) * | 2021-09-03 | 2021-11-30 | 重庆极治医疗科技有限公司 | Electric field cancer treatment equipment with feedback mechanism and diagnosis function and method |
Non-Patent Citations (1)
Title |
---|
神经退行性疾病的光学疗法及其应用展望;魏勋斌等;《中国工程科学》;20200528(第03期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN114392492A (en) | 2022-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3551145B1 (en) | Systems and methods for treating neurological disorders | |
JP7269010B2 (en) | Methods and systems for stimulating the brain | |
CN114392492B (en) | Intelligent nondestructive phototherapy system | |
JP2023528301A (en) | Projection of Defocused Images onto the Peripheral Retina to Treat Refractive Errors | |
TW202145978A (en) | Projection of defocused images on the peripheral retina to treat refractive error | |
KR102114373B1 (en) | System and method for inducing sleep based on auditory stimulation | |
CN104968308A (en) | Devices and methods for improving vision using laser photomiosis | |
KR20130104978A (en) | Tinnitus treating apparatus and method for stimulaitng of hair cell | |
KR20230095973A (en) | Systems and methods for determining modifications or alterations to an initial myopia control solution used by a myopic subject | |
CN218010658U (en) | Intelligent lossless phototherapy glasses | |
CN114392496B (en) | An acousto-optic intelligent non-destructive bone conduction therapy system | |
US20220409849A1 (en) | Systems and methods for electronic patient stimulation and diagnosis | |
CN114041923B (en) | Eye treatment method, equipment and medium for hyperbaric oxygen eyeshade | |
CN115554112A (en) | Visual training methods to improve eyesight | |
TW201924740A (en) | Light source apparatus and wearable apparatus | |
KR20230088888A (en) | Systems and Methods for Determining the Appropriate Time to Modify or Change an Initial Myopia Control Solution | |
CN114099316A (en) | Eye relaxation method and equipment based on high-pressure oxygen eye therapeutic apparatus | |
CN217988181U (en) | An ear-mounted acousto-optic intelligent non-destructive bone conduction therapy instrument | |
EP4506030A1 (en) | Method for applying electrical stimulation to vagus nerve, and vagus nerve stimulation device that reflect user's condition and stimulation sensitivity through biological signal | |
US20240307653A1 (en) | Method and Apparatus for Mitigating Emotional or Physical Tension | |
Yazama et al. | A case of cochlear implantation in a patient with superficial siderosis | |
Vahidi et al. | Bimodal Neurostimulation in Tinnitus Treatment | |
WO2024159210A1 (en) | Methods and systems for providing sensory stimulation to a brain to treat post-traumatic stress disorder | |
WO2025144193A1 (en) | Personalized tinnitus rehabilitation applications with auditory and visual neuromodulation | |
CN118925078A (en) | A cognitive training system and method based on gamma wave multi-sensory stimulation and closed-loop neural regulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |